Biolife Solutions (BLFS) Consolidated Net Income (2010 - 2026)

Biolife Solutions (BLFS) has reported Consolidated Net Income for 17 consecutive years, with $45.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Consolidated Net Income rose 384.78% year-over-year to $45.1 million in Q2 2026; TTM through Jun 2026 was $57.9 million, a 1147.79% increase from a year earlier, with the FY2025 full-year figure at -$4.6 million, up 77.23% from the prior year.
• Consolidated Net Income was $45.1 million for Q2 2026 at Biolife Solutions, up from $1.1 million in the prior quarter.
• Over five years, Consolidated Net Income peaked at $91.0 million in Q4 2022 and troughed at -$72.9 million in Q2 2022.
• A 5-year average of -$2.6 million and a median of -$8.8 million in 2022 frame the typical range for Consolidated Net Income.
• The widest YoY moves for Consolidated Net Income: up 677.99% in 2022, down 13159.49% in 2022.
• Over 5 years, Consolidated Net Income stood at $91.0 million in 2022, then plunged by 116.44% to -$15.0 million in 2023, then jumped by 183.3% to $12.5 million in 2024, then slipped by 11.15% to $11.1 million in 2025, then soared by 307.44% to $45.1 million in 2026.
• The last three Consolidated Net Income figures came in at $45.1 million (Q2 2026), $1.1 million (Q1 2026), and $11.1 million (Q4 2025), per Business Quant data.